中国生物制药(01177.HK) 公布2025年度业绩,收入318.34亿人民币(下同),按年升10.3%。股东应占溢利23.43亿元,按年跌33%;每股盈利13.02分。派末期息5港仙,上年同期派4港仙。连同已派发中期股息每股5港仙,全年合共派发股息每股10港仙。过往派息公布日期派息事项派息内容2025/08/18中期业绩股息:港元 0.05002025/03/20末期业绩股息:港元 ...
Source Link中国生物制药(01177.HK) 公布2025年度业绩,收入318.34亿人民币(下同),按年升10.3%。股东应占溢利23.43亿元,按年跌33%;每股盈利13.02分。派末期息5港仙,上年同期派4港仙。连同已派发中期股息每股5港仙,全年合共派发股息每股10港仙。过往派息公布日期派息事项派息内容2025/08/18中期业绩股息:港元 0.05002025/03/20末期业绩股息:港元 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.